Latest Articlesddd
All the buying and selling of Portola (PTLA) will not make any sense to us until the …
When an investigational gene therapy gets excellent results, the usual reaction towards the developing firm is …
Exciting are the Q2 2018 reported results by Exelixis’ (EXEL) including the firm’s revenues and earnings, …
ProhostLetter #423 TOMORROW’S THERAPEUTICS TODAY For a more or less fair evaluation of biotechnology and pharmaceutical …
The Future is Starting Now Recognizing that the future has already started now is important as …
The Committee for Medicinal Products for Human Use (CHMP) announced a Positive Opinion recommending marketing authorization of Alnylam’s …
AbbVie (NYSE: ABBV), in cooperation with Neurocrine Biosciences (NBIX), announced that the United States FDA approved …
The good news from Biogen’s (BIIB) Q2 exciting financial results comprised impressive news for Ionis (IONS) …
Yesterday’s news unveiled that PTC Therapeutics (PTCT) has entered into an agreement to acquire Agilis Biotherapeutics. The …
Novartis’ (NVS) financials results exceeded analysts’ expectations. The firm’s research institutions’ strategy, well-designed structure, plans for …
A Miracle-Like Gene-Editing That People will Sooner or Later Recognize. The Wellcome Sanger Institute’s new findings …
The BLA Includes Data from More Than 11,000 Patients Amgen (AMGN) and UCB (Euronext Brussels: UCB) …
The Week in Review #26 IN THE BIOTECH WORLD - RESEARCH - IMPROVING CRISPR GENE EDITING The problem …
The New England Journal of Medicine (NEJM) published results from the CELESTIAL phase 3 pivotal trial …
Finally, we are hearing what we were constantly expecting to hear coming out of Compugen’s (CGEN) …
The Week in Review #25 When Stocks Plummet for No Relevant Reasons Sometimes investors need to know …
Health Canada Approves PrSYMDEKO™ For People Ages 12 and Older With Certain CFTR Gene Mutations Vertex …
The FDA approved Array BioPharma’s (ARRY) products Braftovi™ capsules in combination with Mektovi® tablets for unresectable or …
SOPHIRIS BIO AND NANOBIOTIX SOPHIRIS BIO Sophiris Bio (SPHS) has a product called Topsalysin (PRX302) in …
The Week in Review #24 Biotech Stocks’ Performances, Products on the Move and Biotech Research Biotechnology …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
